Tag: Evoxac

Sjögren's syndrome affects an estimated 0.5% to 1.0% of the population, often causing significant dry mouth (xerostomia) [1.7.2]. A key question for those prescribed treatment is, **what are the side effects of cevimeline?**

For the approximately 90% of individuals with Sjögren's syndrome who experience dry mouth (xerostomia), understanding **when to take cevimeline** is a crucial part of managing symptoms effectively. This medication works by increasing the body's natural saliva production, and its effectiveness depends heavily on a consistent dosing schedule.

Cevimeline, marketed under the brand name Evoxac, is a cholinergic agonist that stimulates saliva production. But for those with Sjögren's syndrome, correctly knowing **when should I take cevimeline** is a crucial step towards effective symptom relief.

Cevimeline, known by the brand name Evoxac®, was approved for use in the United States in 2000. A prescription cholinergic agonist, it is primarily used to address the symptoms of dry mouth (xerostomia) in adults with Sjögren’s syndrome.